In a groundbreaking shift, U.S. obesity rates are potentially on the decline, according to new data highlighted by EURweb. This change is partly attributed to the ‘Ozempic Effect,’ where the use of GLP-1 medications such as Ozempic is becoming increasingly popular in managing weight loss and diabetes. These drugs, originally designed to treat type 2 diabetes, are now being heralded for their effectiveness in aiding significant weight reduction. Experts suggest that the rise in prescriptions for medications like Ozempic and positive lifestyle changes may be contributing to the first meaningful decrease in obesity rates in the U.S. in decades. While this trend is encouraging, health professionals caution that continued commitment to healthy living is necessary to sustain progress. The potential decline in obesity could lead to long-term health benefits and reduced strain on the healthcare system. This intriguing development underscores the critical role of innovative medical treatments in addressing chronic health issues.
EURwebNew data shows Oklahoma City Eviction Rate Soars Above New York City
June 23, 2026
Recent findings highlight a concerning trend in Oklahoma City, with eviction rates now more than double those of New York City. This stark contrast raises